Uterine Fibroids Clinical Trials

A listing of Uterine Fibroids medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 7 clinical trials
Featured trial
Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM

names of the study drugs involved in this study are:

<ul>
  • Iberdomide (a type of cereblon E3 ligase modulator)
  • Elotuzumab (a type of monoclonal antibody)
  • Dexamethasone (a type of

    • 0 views
    • 03 Jul, 2025
    • 1 location
    Featured trial
    Auricular Acupressure for Premenstrual Syndrome in Female Students

    in female undergraduate students. The main questions it aims to answer are:

    <ul>
  • Does auricular acupressure reduce the severity of PMS symptoms in female undergraduate students?
  • Is

    • 0 views
    • 20 May, 2025
    Featured trial
    Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

    This is a phase II study to evaluate the outpatient administration of Teclistamab or Talquetamab in Multiple Myeloma patients

    • 0 views
    • 03 Jul, 2025
    • 16 locations
    Featured trial
    Minimal Residual Disease Guided Maintenance Therapy With Belantamab Mafodotin and Lenalidomide After Autologous Hematopoietic Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma

    To increase the conversion rate from MRD-positive to MRD-negative CR in patients with newly diagnosed multiple myeloma (NDMM) receiving post-transplant maintenance therapy with belantamab mafodotin plus lenalidomide.

    Accepts healthy volunteers
    • 0 views
    • 03 Jul, 2025
    • 1 location
    Featured trial
    Bortezomib-bendamustine-melphalan vs Melphalan for Multiple Myeloma

    This project will evaluate the efficacy and safety of the conditioning regimen bortezomib-bendamustine-melphalan (BBM) in combination with autologous hematopoietic stem cell transplantation (ASCT) in relapsed multiple myeloma given from 2011 to 2018 at Uppsala University Hospital. This approach will be retrospectively compared to high dose melphalan (HDM) in the same …

    • 0 views
    • 24 Jun, 2025
    International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab

    <ul>

  • This is a multi-center, open-label, Phase 2 treatment extension study in patients with multiple myeloma who are still benefitting from isatuximab based therapy following completion of a

    dexamethasone
    lenalidomide
    • 0 views
    • 03 Jul, 2025
    • 23 locations
    A Phase 3 Randomized, Open-label, Multicenter Study of Isatuximab (SAR650984) in Combination With Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With High-risk Smoldering Multiple Myeloma  

    Primary Objectives:

    <ul>
  • Safety run-in: To confirm the recommended dose of isatuximab when combined with lenalidomide and dexamethasone in participants with high-risk

    dexamethasone
    lenalidomide
    neutrophil count
    bone marrow procedure
    • 0 views
    • 03 Jul, 2025
    • 9 locations